- Nachrichtendetail
-
13.09.2023 15:02:20 - dpa-AFX: *NEKTAR ANNOUNCES PROMISING NEW DATA FROM PHASE 1B STUDY OF REZPEGALDESLEUKIN IN ATOPIC DERMATITIS
Copyright(c) 2023 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Nektar Therapeutics | 165417 | NASDAQ | 1,160 | 21.06.24 23:21:21 | +0,070 | +6,42% | 1,110 | 1,150 | 1,080 | 1,160 |
